Related references
Note: Only part of the references are listed.Trastuzumab and Hypofractionated Whole Breast Radiotherapy: A Victorious Combination?
Maria Carmen De Santis et al.
CLINICAL BREAST CANCER (2018)
Hypofractionated boost after whole breast irradiation in breast carcinoma: chronic toxicity results and cosmesis
J. Sanz et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
Short course hypofractionated whole breast irradiation after conservative surgery: a single institution phase II study
Paola Pinnaro et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer
Domenico Cante et al.
MEDICAL ONCOLOGY (2017)
Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial
Leen Paelinck et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial A Randomized Clinical Trial
Conny Vrieling et al.
JAMA ONCOLOGY (2017)
Relation between Hypofractionated Radiotherapy, Toxicity and Outcome in Early Breast Cancer
Francesca De Felice et al.
BREAST JOURNAL (2017)
Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India
Dodul Mondal et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2017)
Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy
M. C. De Santis et al.
BREAST (2016)
Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity
Isabel Linares et al.
CLINICAL BREAST CANCER (2016)
Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial
Stuti Ahlawat et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Hypofractionated radiation therapy for breast cancer: long-term results in a series of 85 patients
Letizia Deantonio et al.
TUMORI JOURNAL (2016)
Hypofractionated radiation therapy for breast cancer: long-term results in a series of 85 patients
Letizia Deantonio et al.
TUMORI JOURNAL (2016)
Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors
Patrizia Ciammella et al.
RADIATION ONCOLOGY (2014)
Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: a retrospective analysis of acute skin toxicity and dose inhomogeneities
Grazia Tortorelli et al.
BMC CANCER (2013)
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials
Joanne S. Haviland et al.
LANCET ONCOLOGY (2013)
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
LANCET (2011)
Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years
Paola Pinnaro et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials
Penelope Hopwood et al.
LANCET ONCOLOGY (2010)
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
Timothy J. Whelan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects
Marina Guenzi et al.
RADIATION ONCOLOGY (2010)
Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity
Letizia Deantonio et al.
RADIATION ONCOLOGY (2010)
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial
LANCET (2008)
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial
LANCET ONCOLOGY (2008)
Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial
J. Roger Owen et al.
LANCET ONCOLOGY (2006)
Dermatologic toxicity of chemotherapeutic agents
AS Payne et al.
SEMINARS IN ONCOLOGY (2006)
Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial
J Yarnold et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Share Paper
